|
[1]WU BY, DONG HL, WANG ZX, et al.Effect of life table on of the average life expectancy from malignant tumors[J].Mod Prevent Med, 2015, 42 (23) :4328-4331. (in Chinese) 吴炳义, 董惠玲, 王在翔, 等.恶性肿瘤对平均预期寿命影响的生命表分析[J].现代预防医学, 2015, 42 (23) :4328-4331.
|
|
[2]STOTTER A, REED MW, GRAY LJ, et al.Comprehensive geriatric assessment and predicted 3-year survival in treatment planning for frail patients with early breast cancer[J].Br J Surg, 2015, 102 (5) :525-533.
|
|
[3]ZHENG R, ZENG H, ZHANG S, et al.National estimates of cancer prevalence in China, 2011[J].Cancer Lett, 2016, 370 (1) :33-38.
|
|
[4]TORRE LA, BRAY F, SIEGEL RL, et al.Global cancer statistic, 2012[J].CA Cancer J Clin, 2015, 65 (2) :87-108.
|
|
[5]MIRICI-CAPPA F, GRAMENZI A, SANTI V, et al.Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients:A 20-year multicentre experience[J].Gut, 2010, 59 (3) :387-396.
|
|
[6]LIANG HY, LU ZM.Current status and confusion in comprehensive interventional therapy for hepatocellular carcinoma[J].J Clin Hepatol, 2016, 32 (1) :44-48. (in Chinese) 梁宏元, 卢再鸣.原发性肝癌综合介入治疗现状与困惑[J].临床肝胆病杂志, 2016, 32 (1) :44-48.
|
|
[7]JIANG HT, CAO JY.Impact of laparoscopic versus open hepatectomy on perioperative clinical outcomes of patients with primary hepatic carcinoma[J].Chin Med Sci J, 2015, 30 (2) :80-83.
|
|
[8]OISHI K, ITAMOTO T, KOHASHI T, et al.Safety of hepatectomy for elderly patients with hepatocellular carcinoma[J].World J Gastroenterol, 2014, 20 (41) :15028-15036.
|
|
[9]IGUCHI T, SHIRABE K, AISHIMA S, et al.New pathologic stratification of microvascular invasion in hepatocellular carcinoma:predicting prognosis after living-donor liver transplantation[J].Transplantation, 2015, 99 (6) :1236-1242.
|
|
[10]LI Y.Early in patients with primary liver cancer treatment decision aid scheme of construction and application of research[D].Acad JSecond Military Med Univ, 2017. (in Chinese) 李玉.早期原发性肝癌患者治疗决策辅助方案的构建与应用研究[D].第二军医大学, 2017.
|
|
[11]LU LG.Advances in early screening and diagnosis of hepatocellular carcinoma[J].J Clin Hepatol, 2017, 33 (7) :1257-1261. (in Chinese) 陆伦根.原发性肝癌的早期筛查及诊断[J].临床肝胆病杂志, 2017, 33 (7) :1257-1261.
|
|
[12]WANG DD, WU LQ, WANG ZS.Prognosis of hepatocellular carcinoma with bile duct tumor thrombus after R0 resection:A matched study[J].Hepatobiliary Pancreat Dis Int, 2016, 15 (6) :626-632.
|
|
[13]GAO ZH, BAI DS, JIANG GQ, et al.Review of preoperative transarterial chemoembolization for resectable hepatocellular carcinoma.[J].World J Hepatol, 2015, 7 (1) :40-43.
|
|
[14]HONDA T, MIYAAKI H, ICHIKAWA T, et al.Clinical characteristics of hepatocellular carcinoma in elderly patients[J].Oncol Lett, 2011, 2 (5) :851-854.
|
|
[15]COHEN MJ, BLOOM AI, BARAK O, et al.Trans-arterial chemo-embolization is safe and effective for very elderly patients with hepatocellular carcinoma[J].World J Gastroenterol, 2013, 19 (16) :2521-2528.
|
|
[16]KAO WY, CHIOU YY, HUNG HH, et al.Younger hepatocellular carcinoma patients have better prognosis after percutaneous radiofrequency ablation therapy[J].J Clin Gastroenterol, 2012, 46 (1) :62-70.
|
|
[17]SU CW, LEI HJ, CHAU GY, et al.The effect of age on the longterm prognosis of patients with hepatocellular carcinoma after resection surgery:A propensity score matching analysis[J].Arch Surg, 2012, 147 (2) :137-144.
|
|
[18]NISHIKAWA H, ARIMOTO A, WAKASA T, et al.Surgical resection for hepatocellular carcinoma:Clinical outcomes and safety in elderly patients[J].Eur J Gastroenterol Hepatol, 2013, 25 (8) :912-919.
|
|
[19]REDDY SK, BARBAS AS, TURLEY RS, et al.Major liver resection in elderly patients:a multi-institutional analysis[J].J Am Coll Surg, 2011, 212 (5) :787-795.
|
|
[20]NISHIKAWA H, KIMURA T, KITA R, et al.Treatment for hepatocellular carcinoma in elderly patients:A literature review[J].J Cancer, 2013, 4 (8) :635-643.
|
|
[21]GUO ZQ, WANG QY, QI XS, et al.Recommendations for the diagnosis and management of nonalcoholic fatty liver disease:Practice guidance from the American Association for the Study of Liver Diseases (2017) [J].J Clin Hepatol, 2017, 33 (12) :2275-2277. (in Chinese) 郭泽淇, 王倩怡, 祁兴顺, 等.《2017年美国肝病学会非酒精性脂肪性肝病诊疗指导》摘译[J].临床肝胆病杂志, 2017, 33 (12) :2275-2277.
|
|
[22]ZOU WL, GU XF.Analysis on the correlation of diabetes and IFG/IGT with NAFLD[J].Chin J Intradit West Med Liver Dis, 2017, 27 (6) :334-335. (in Chinese) 邹文兰, 顾学芳.2型糖尿病和糖代谢异常/糖耐量异常与非酒精性脂肪肝的相关性研究[J].中西医结合肝病杂志, 2017, 27 (6) :334-335.
|
|
[23]WANG LH, XIONG QF, YANG YF.Analysis of the clinical characteristics of primary liver cancer and the influencing factors of prognosis[J].Pract Geriatr, 2017, 31 (12) :1135-1137. (in Chinese) 王华利, 熊清芳, 杨永峰.279例老年原发性肝癌临床特点及预后影响因素分析[J].实用老年医学, 2017, 31 (12) :1135-1137.
|
|
[24]KESWANI RN, AHMED A, KEEFFE EB.Older age and liver transplantation:A review[J].Liver Transpl, 2004, 10 (8) :957-967.
|
|
[25]KIM J, KO ME, NELSON RA, et al.Increasing age and survival after orthotopic liver transplantation for patients with hepatocellular cancer[J].J Am Coll Surg, 2014, 218 (3) :431-438.
|
|
[26]XUE H.The decision tree model of liver resection and radiofrequency ablation in Milan standard[D].Acad J Second Military Med Univ, 2016. (in Chinese) 薛辉.米兰标准的老年肝癌肝切除与射频消融治疗的决策树模型[D].第二军医大学, 2016.
|
|
[27]CHANG M, HAO J.Laparoscopic hepatectomy for the treatment of senile primary small liver cancer clinical efficacy[J].Pop Sci Tech, 2015, 17 (12) :69-70. (in Chinese) 常明, 赫军.腹腔镜肝切除术治疗老年原发性微小肝癌的临床疗效[J].大众科技, 2015, 17 (12) :69-70.
|
|
[28]BOOTHE HW Jr.Current concepts in hepatobiliary surgery[J].Vet Clin North Am Small Anim Pract, 2015, 45 (3) :463-475.
|
|
[29]KAIBORI M, MATSUI K, ISHIZAKI M, et al.Hepatic resection for hepatocellular carcinoma in the elderly[J].J Surg Oncol, 2009, 99 (3) :154-160.
|
|
[30]MOHANTY S, BERLINER L, SHAH S.Surgical treatment for hepatocellular carcinoma[M]//An Information Technology Framework for Predictive, Preventive and Personalised Medicine.Springer International Publishing, 2015:1-15.
|
|
[31]YAMADA S, SHIMADA M, MIYAKE H, et al.Outcome of hepatectomy in super-elderly patients with hepatocellular carcinoma[J].Hepatol Res, 2012, 42 (5) :454-458.
|
|
[32]NOZAWA A, KUBO S, TAKEMURA S, et al.Hepatic resection for hepatocellular carcinoma in super-elderly patients aged 80years and older in the first decade of the 21st century[J].Surg Today, 2015, 45 (7) :851-857.
|
|
[33]SULPICE L, RAYAR M, CAMPILLO B, et al.Advanced age remains an Achilles heel for liver resections[J].World J Surg, 2013, 38 (4) :918-926.
|
|
[34]ZHAI YP, WANG HY, WANG Y, et al.Ultrasound-guided radiofrequency ablation for the treatment of elderly cancer of the liver and tumor residual risk factors[J].Chin J Gerontol, 2017, 37 (10) :2475-2477. (in Chinese) 翟渊鹏, 王海英, 王雁, 等.超声引导射频消融治疗老年肝癌的效果及肿瘤残留的危险因素[J].中国老年学杂志, 2017, 37 (10) :2475-2477.
|
|
[35]XIAO R, TIAN H, HU XD, et al.Influencing factors of microwave ablation on tumor-free survival rate in treatment of primary liver cancer[J].Hebei Med J, 2018, 40 (2) :277-279, 284. (in Chinese) 肖蓉, 田虹, 胡晓丹, 等.微波消融治疗老年原发性肝癌患者的无瘤生存影响因素分析[J].河北医药, 2018, 40 (2) :277-279, 284.
|
|
[36]de GIORGIO M, VEZZOLI S, COHEN E, et al.Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria[J].Liver Transpl, 2010, 16 (4) :503-512.
|
|
[37]TATEISHI R, SHIINA S, TERATANI T, et al.Percutaneous radiofrequency ablation for hepatocellular carcinoma[J].Cancer, 2005, 103 (6) :1201-1209.
|
|
[38]SATO M, TATEISHI R, YASUNAGA H, et al.Mortality and morbidity of hepatectomy, radiofrequency ablation, and embolization for hepatocellular carcinoma:A national survey of 54, 145 patients[J].J Gastroenterol, 2012, 47 (10) :1125-1133.
|
|
[39]NISHIKAWA H, KITA R, KIMURA T, et al.Transcatheter arterial chemoembolization for intermediate-stage hepatocellular carcinoma:Clinical outcome and safety in elderly patients[J].J Cancer, 2014, 5 (7) :590-597.
|
|
[40]CHEN J, JIN R, ZHAO J, et al.Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma[J].Cancer Lett, 2015, 367 (1) :1-11.
|
|
[41]ZHAO Y, LIU T, SHEN XJ, et al.Clinical analysis of advanced hepatocellular carcinoma patients treated with sorafenib[J].Chin J Curr Adv Gen Surg, 2015, 18 (8) :601-604. (in Chinese) 赵益, 刘涛, 沈象吉, 等.索拉非尼治疗中晚期肝细胞肝癌的临床分析[J].中国现代普通外科进展, 2015, 18 (8) :601-604.
|
|
[42]DI COSTANZO GG, TORTORA R, DE LM, et al.Impact of age on toxicity and efficacy of sorafenib-targeted therapy in cirrhotic patients with hepatocellular carcinoma[J].Med Oncol, 2013, 30 (1) :446.
|
|
[43]WONG H, TANG YF, YAO TJ, et al.The outcomes and safety of single-agent sorafenib in the treatment of elderly patients with advanced hepatocellular carcinoma (HCC) [J].Oncologist, 2011, 16 (12) :1721-1728.
|
|
[44]JO M, YASUI K, KIRISHIMA T, et al.Efficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinoma[J].Hepatol Res, 2014, 44 (13) :1329-1338.
|
|
[45]IAVARONE M, CABIBBO G, PISCAGLIA F, et al.Field-practice study of sorafenib therapy for hepatocellular carcinoma:A prospective multicenter study in Italy[J].Hepatol, 2011, 54 (6) :2055-2063.
|
|
[46]MORIMOTO M, NUMATA K, KONDO M, et al.Higher discontinuation and lower survival rates are likely in elderly Japanese patients with advanced hepatocellular carcinoma receiving sorafenib[J].Hepatol Res, 2011, 41 (4) :296-302.
|
|
[47]EDELINE J, CROUZET L, LE SS, et al.Sorafenib use in elderly patients with hepatocellular carcinoma:caution about use of platelet aggregation inhibitors[J].Cancer Chemother Pharmacol, 2015, 75 (1) :215-219.
|
DownLoad: